Luis Garratón Listed by sinobi Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

Ransomware groups continue to target mid-sized distributors and logistics firms that sit at the intersection of healthcare supply chains and consumer goods, using data theft as leverage even when encryption outcomes remain unclear. In this environment, a listing on a criminal leak site often becomes the first public signal that an organisation has been hit, long before any independent confirmation of scale or impact emerges.

On 27 October 2025, the ransomware group known as sinobi publicly listed Luis Garratón as a victim, claiming that internal files had been exfiltrated during a ransomware attack. The number of people affected remains unknown, and no further technical details about the intrusion have been disclosed. For clients, partners and employees of a pharmaceutical and logistics distributor, the listing raises practical questions about what information may now be circulating and what steps are warranted.

Inside the incident

Public reporting states only that Luis Garratón was listed by the sinobi ransomware group on 27 October 2025. The group asserts that internal files were exfiltrated as part of a ransomware attack. No independent confirmation of the intrusion method, the precise date of compromise, the volume of data taken, or whether systems were encrypted has been released. The number of individuals potentially affected is listed as unknown. Beyond the claim of internal-file exfiltration, the contents of any stolen material have not been itemised in available accounts. In short, the incident is known primarily through the group’s leak-site listing; operational and forensic particulars remain undisclosed.

The group behind it: sinobi

Sinobi is a ransomware operation that follows the now-familiar double-extortion model: after gaining access to a network, operators typically steal data and then threaten to publish it unless a ransom is paid. Like many contemporary groups, sinobi maintains a dedicated leak site on which it names victims and, in some cases, releases sample files or full archives. Public reporting on the group describes the use of common initial-access vectors such as compromised credentials or vulnerable remote services, followed by lateral movement and data staging. Prior listings by sinobi have involved organisations across manufacturing, distribution and professional services, though each claim must be evaluated on its own evidence. In the present case the group claims that Luis Garratón suffered a ransomware attack involving the exfiltration of internal files; that assertion has not been independently verified in the material available.

Luis Garratón and its sector

Luis Garratón, LLC is described as a full-service distributor specialising in pharmaceutical products, consumer goods and logistics services. The company organises its work around four main categories—healthcare, consumer products, logistics and digital marketing—and positions itself as a partner that helps clients meet commercial objectives through a dedicated sales force. Organisations of this type routinely handle product catalogues, shipping records, client contracts, inventory data and, in the healthcare segment, information linked to regulated pharmaceutical distribution. Because such firms sit between manufacturers, pharmacies, retailers and end customers, a compromise can affect not only the distributor’s own operations but also the confidentiality of partner and supply-chain data. A breach claim against a company operating in pharmaceutical logistics therefore carries wider implications for the integrity of distribution channels that many patients and businesses rely upon.

What data was at risk

The only data type named in connection with the incident is “internal files” said to have been exfiltrated. No further breakdown—such as whether those files contained customer lists, invoices, employee records, shipping manifests or pharmaceutical-related documentation—has been provided. Organisations in this sector typically hold commercial contracts, inventory and logistics records, client contact details and, depending on the healthcare component of their business, information subject to pharmaceutical-distribution regulations. Because the exact contents remain unconfirmed, it is not possible to state which specific categories of personal or commercial data, if any, left the organisation’s control. The claim of internal-file exfiltration is the sole public characterisation available.

What's at stake

For individuals whose information may have been among the internal files, the practical risks include unwanted contact, targeted phishing that references genuine business relationships, or the misuse of any personal identifiers that happened to be stored. For business partners, the exposure of contractual or logistics data could reveal commercial terms or shipment patterns that competitors or fraudsters might exploit. The organisation itself faces potential disruption to operations, the cost of investigation and remediation, and the longer-term task of restoring confidence among clients who depend on reliable pharmaceutical and consumer-goods distribution. Because the scale of the incident and the precise data involved are unknown, these risks remain potential rather than quantified; they are nonetheless real enough to warrant prudent monitoring by anyone who has dealt with the company.

What to do if you're exposed

If you have a past or present relationship with Luis Garratón—whether as a customer, supplier, employee or partner—treat the listing as a prompt to review your own exposure. Monitor financial and email accounts for unusual activity, be sceptical of unsolicited messages that reference the company or its products, and consider placing fraud alerts with credit bureaus if personal identifiers were ever shared. Change passwords on any accounts that reused credentials associated with the organisation, and enable multi-factor authentication wherever possible. Readers can also run a free exposure scan of their email address to check whether that address has already appeared in known breach data sets; such a check provides an additional, independent signal of whether personal information has circulated beyond this single incident.

AICompiled with AI assistance from public sources and published under our editorial standards.